Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia

Abstract

Contrary to previous findings, we found no evidence that two weeks of exogenous melatonin is effective in improving sleep in people with dementia, although possible benefits of melatonin following longer periods of administration cannot be discounted.